Fertility and Sterility
Volume 91, Issue 2 , Pages 542-548 , February 2009

Low serum osteoprotegerin levels in premenopausal infertile women with low bone density: an association of relevance?

  • John M. Norian, MD.

      Affiliations

    • Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
    • ,
  • Gohar Zeitlian, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology and Women's Health, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York
    • Division of Reproductive Endocrinology and Infertility, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York
    • ,
  • Goli Adel, B.S.

      Affiliations

    • Department of Obstetrics and Gynecology and Women's Health, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York
    • Division of Reproductive Endocrinology and Infertility, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York
    • ,
  • Ruth G. Freeman, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology and Women's Health, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York
    • ,
  • Nanette F. Santoro, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology and Women's Health, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York
    • Division of Reproductive Endocrinology and Infertility, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York
    • ,
  • Lubna Pal, M.B.B.S., MRCOG, M.S.

      Affiliations

    • Department of Obstetrics and Gynecology and Reproductive Sciences, Division of Reproductive Endocrinology and Infertility, Yale University School of Medicine, New Haven, Connecticut
    • Corresponding Author InformationReprint requests: Lubna Pal, M.B.B.S., MRCOG, M.S., Department Of Obstetrics and Gynecology and Reproductive Sciences, Division of Reproductive Endocrinology and Infertility, Yale University School of Medicine, 333 Cedar Street, P.O. Box 208063, New Haven, CT 06520 (FAX: 203-785-7134).

Received 4 September 2007 ,Revised 28 November 2007 ,Accepted 28 November 2007.

References 

  1. Facts and statistics about osteoporosis and its impact. © Copyright 1999–2007 International Osteoporosis Foundation. Available at: http://www.iofbonehealth.org/facts-and-statistics.html. Last accessed April 22, 2008.
  2. Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, et al. Bone density at various sites for prediction of hip fractures. Study of Osteoporotic Fractures Research Group. Lancet. 1993;341:72–75
  3. Brown DM, Jowsey J, Bradford DS. Osteoporosis in ovarian dysgenesis. J Pediatr. 1974;84:816–820
  4. Uygur D, Sengul O, Bayar D, Erdinc S, Batioglu S, Mollamahmutoglu L. Bone loss in young women with premature ovarian failure. Arch Gynecol Obstet. 2005;273:17–19
  5. Lucas AR, Melton LJ, Crowson CS, O'Fallon WM. Long-term fracture risk among women with anorexia nervosa: a population-based cohort study. Mayo Clin Proc. 1999;74:972–977
  6. White CM, Hergenroeder AC, Klish WJ. Bone mineral density in 15- to 21-year-old eumenorrheic and amenorrheic subjects. Am J Dis Child. 1992;146:31–35
  7. Melton LJ, Hesdorffer DC, Malkasian GD, Atkinson EJ, Brinton LA, O'Fallon WM. Long-term fracture risk among infertile women: a population-based cohort study. J Womens Health Gend Based Med. 2001;10:289–297
  8. Ahlborg HG, Johnell O, Nilsson BE, Jeppsson S, Rannevik G, Karlsson MK. Bone loss in relation to menopause: a prospective study during 16 years. Bone. 2001;28:327–331
  9. Sowers M, Crutchfield M, Bandekar R, Randolph JF, Shapiro B, Schork MA, et al. Bone mineral density and its change in pre- and perimenopausal white women: the Michigan Bone Health Study. J Bone Miner Res. 1998;13:1134–1140
  10. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res. 2000;15:1526–1536
  11. Khan AA, Syed Z. Bone densitometry in premenopausal women. J Clin Densitom. 2004;7:85–92
  12. Khan A, Syed Z. Bone mineral density assessment in premenopausal women. Future Med. 2006;2:639–645
  13. Lewiecki EM. Low bone mineral density in premenopausal women. South Med J. 2004;97:544–550
  14. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89:309–319
  15. Rogers A, Eastell R. Circulating osteoprotegerin and receptor activator for nuclear factor κB ligand: clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab. 2005;90:6323–6331
  16. Mizuno A, Amizuka N, Irie K, Murakami A, Fujise N, Kanno T, et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Comm. 1998;247:610–615
  17. McClung MR, Lewiecki EM, Cohen SB, Bolognese MA, Woodson GC, Moffett AH, et al. Denosumab in postmenopausal women with low bone mineral density. N Engl J Med. 2006;354:821–831
  18. Achilles InSight, Imaging Bone Ultrasonometer. Waukesha, WI: General Electric Medical Systems; 2004;
  19. Martin JS, Nisker JA, Tummon IS, Daniel SA, Auckland JL, Feyles V. Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels. Fertil Steril. 1996;65:1238–1240
  20. Bowen S, Norian J, Santoro N, Pal L. Simple tools for assessment of ovarian reserve (OR): individual ovarian dimensions are reliable predictors of OR. Fertil Steril. 2007;88:390–395
  21. Kurth T, Walker AM, Glynn RJ, Chan KA, Gaziano JM, Berger K, et al. Results of multivariable logistic regression, propensity matching, propensity adjustment and propensity based weighting under conditions of non union effect. Am J Epidemiol. 2006;163:262–270
  22. Fahrleitner A, Prenner G, Leb G, Tscheliessnigg KH, Piswanger-Solkner C, Obermayer-Pietsch B, et al. Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation. Bone. 2003;32:96–106
  23. Khosla S, Arrighi HM, Melton LJ, Atkinson EJ, O'Fallon WM, Dunstan C, et al. Correlates of osteoprotegerin levels in women and men. Osteoporos Int. 2002;13:394–399
  24. Yano K, Tsuda E, Washida N, Kobayashi F, Goto M, Harada A, et al. Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. J Bone Miner Res. 1999;14:518–527
  25. Arrighi HM, Khosla S, Melton LJ, Riggs BL, Bekker PJ, Dunstan CR. The relationship between circulating osteoprotegerin and estrogen in postmenopausal women. J Bone Miner Res. 2000;15:S118
  26. Torstveit MK, Sundgot-Borgen J. Low bone mineral density is two to three times more prevalent in non-athletic premenopausal women than in elite athletes: a comprehensive controlled study. Br J Sports Med. 2005;39:282–287
  27. Hawker GA, Jamal SA, Ridout R, Chase C. A clinical prediction rule to identify premenopausal women with low bone mass. Osteoporos Int. 2002;13:400–406
  28. Rogers A, Saleh G, Hannon RA, Greenfield D, Eastell R. Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women. J Clin Endocrinol Metab. 2002;87:4470–4475
  29. Sowers M, Randolph JF, Crutchfield M, Jannausch ML, Shapiro B, Zhang B, et al. Urinary ovarian and gonadotropin hormone levels in premenopausal women with low bone mass. J Bone Miner Res. 1998;13:1191–1202
  30. Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, et al. FSH directly regulates bone mass. Cell. 2006;125:247–260
  31. Hawa G, Brinskelle-Schmal N, Glatz K, Maitzen S, Woloszczuk W. Immunoassay for soluble RANKL (receptor activator of NF-κB ligand) in serum. Clin Lab. 2003;49:461–463
  32. Hans D, Dargent-Molina P, Schott AM, Sebert JL, Cormier C, Kotzki PO, et al. Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet. 1996;348:511–514

 Funding provided by U.S. National Institutes of Health 5K12 RR17672 (to LP).

 Presented in part at the 28th annual meeting of the American Society for Bone and Mineral Research, Philadelphia, Pennsylvania, September 15–19, 2006.

PII: S0015-0282(07)04154-4

doi: 10.1016/j.fertnstert.2007.11.089

Fertility and Sterility
Volume 91, Issue 2 , Pages 542-548 , February 2009

Article Tools

* Image Usage & Resolution